| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to antiretroviral therapy: supervision or support?
|
Mills, Edward J
|
|
2012
|
12 |
2 |
p. 97-98
2 p.
|
artikel
|
| 2 |
Australia publishes hospital staphylococcus bacteraemia rates
|
Kirby, Tony
|
|
2012
|
12 |
2 |
p. 105-106
2 p.
|
artikel
|
| 3 |
Crowd and environmental management during mass gatherings
|
Johansson, Anders
|
|
2012
|
12 |
2 |
p. 150-156
7 p.
|
artikel
|
| 4 |
Dampening the effect of drug resistance in HIV: a leap forward
|
Lundgren, Jens D
|
|
2012
|
12 |
2 |
p. 91-92
2 p.
|
artikel
|
| 5 |
Direct faecal PCR for diagnosis of Shiga-toxin-producing Escherichia coli
|
Gerritzen, A
|
|
2012
|
12 |
2 |
p. 102-
1 p.
|
artikel
|
| 6 |
Dissemination of NDM-1
|
Sahai, Sanjeev
|
|
2012
|
12 |
2 |
p. 100-101
2 p.
|
artikel
|
| 7 |
Dissemination of NDM-1
|
Hasan, Badrul
|
|
2012
|
12 |
2 |
p. 99-100
2 p.
|
artikel
|
| 8 |
Dissemination of NDM-1
|
Garg, Atul
|
|
2012
|
12 |
2 |
p. 99-
1 p.
|
artikel
|
| 9 |
Dissemination of NDM-1 – Authors' reply
|
Walsh, Timothy R
|
|
2012
|
12 |
2 |
p. 101-102
2 p.
|
artikel
|
| 10 |
Dolutegravir—a promising antiretroviral in development
|
Boyd, Mark
|
|
2012
|
12 |
2 |
p. 90-91
2 p.
|
artikel
|
| 11 |
Drug donated for treatment of visceral leishmaniasis
|
Burki, Talha
|
|
2012
|
12 |
2 |
p. 107-108
2 p.
|
artikel
|
| 12 |
Erratum
|
|
|
2012
|
12 |
2 |
p. 98-
1 p.
|
artikel
|
| 13 |
Erratum
|
|
|
2012
|
12 |
2 |
p. 98-
1 p.
|
artikel
|
| 14 |
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis
|
Tate, Jacqueline E
|
|
2012
|
12 |
2 |
p. 136-141
6 p.
|
artikel
|
| 15 |
For sepsis, the drugs don't work
|
The Lancet Infectious Diseases,
|
|
2012
|
12 |
2 |
p. 89-
1 p.
|
artikel
|
| 16 |
Genital HPV types in Australia
|
Brotherton, Julia
|
|
2012
|
12 |
2 |
p. 102-103
2 p.
|
artikel
|
| 17 |
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial
|
Estívariz, Concepción F
|
|
2012
|
12 |
2 |
p. 128-135
8 p.
|
artikel
|
| 18 |
Inactivated polio vaccine and global polio eradication
|
Modlin, John F
|
|
2012
|
12 |
2 |
p. 93-94
2 p.
|
artikel
|
| 19 |
Infectious disease surveillance update
|
Christodoulou, Mario
|
|
2012
|
12 |
2 |
p. 108-
1 p.
|
artikel
|
| 20 |
Is Escherichia coli bacteraemia preventable?
|
Melzer, Mark
|
|
2012
|
12 |
2 |
p. 103-104
2 p.
|
artikel
|
| 21 |
Non-communicable health risks during mass gatherings
|
Steffen, Robert
|
|
2012
|
12 |
2 |
p. 142-149
8 p.
|
artikel
|
| 22 |
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
|
van Lunzen, Jan
|
|
2012
|
12 |
2 |
p. 111-118
8 p.
|
artikel
|
| 23 |
Partnering to heal
|
Nicolle, Lindsay E
|
|
2012
|
12 |
2 |
p. 110-
1 p.
|
artikel
|
| 24 |
Research brief
|
Bradbury, Jane
|
|
2012
|
12 |
2 |
p. 109-
1 p.
|
artikel
|
| 25 |
Surgical treatment of drug-resistant tuberculosis
|
Kempker, Russell R
|
|
2012
|
12 |
2 |
p. 157-166
10 p.
|
artikel
|
| 26 |
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study
|
|
|
2012
|
12 |
2 |
p. 119-127
9 p.
|
artikel
|
| 27 |
Updating prevaccination rotavirus-associated mortality
|
Desselberger, Ulrich
|
|
2012
|
12 |
2 |
p. 94-96
3 p.
|
artikel
|
| 28 |
Why doesn't hand hygiene work better?
|
Sepkowitz, Kent A
|
|
2012
|
12 |
2 |
p. 96-97
2 p.
|
artikel
|
Tijdschrift beschrijving